Detection of Circulating Tumour Cells, Spread Through Air Space in Patients With Lung Cancer

Recruiting now

Conditions studied: Non-Small-Cell Lung Cancer

In brief

The aim of this study is to evaluate the prognostic impact of the presence of circulating tumour cells Circulating Tumour Cells (CTCs), Spread Through Air Space (STAS) and lymph node micrometastases in patients undergoing radical surgery for non-small cell lung neoplasia

Key facts

Study ID

NCT06833632

Run by

IRCCS Azienda Ospedaliero-Universitaria di Bologna

People needed

100

Starts

2023-05-25

Expected to finish

2025-09-11

Last updated by the study team

2025-02-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• obtaining voluntary written informed consent
• diagnosis of NSCLC
• clinical stage I-IIA cN0
• Candidates for surgical resection

You may not qualify if…

• Pregnancy
• Induction therapy for pulmonary neoplasia
• Patients who have received systemic treatment for previous cancers in the last three years prior to lung surgery
• Any previous surgery for lung cancer
• Patients with other active neoplasms
• Infiltration of the chest wall

Where it is running

• IRCCS - Azienda Ospedaliero Universitaria di Bologna — Bologna, Emilia-Romagna, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.